Information

Minoxidil is a vasodilatory drug originally developed and FDA-approved in 1979 as a treatment for severe, refractory hypertension at doses of 10–40 mg daily. During clinical trials at those doses, a near-universal side effect was observed as excessive hair growth (hypertrichosis). This led to the development of a topical formulation, which became the first FDA-approved treatment for hair loss in 1987 and remains the only FDA-approved topical option today.

Today, minoxidil is available in two forms: topical (2% and 5% solution or foam, FDA-approved) and oral low-dose (0.25–5 mg/day, used off-label).

Off-label use of oral minoxidil is prescribed for:

• Androgenetic alopecia (AGA, male or female-pattern baldness)
• Telogen effluvium (TE, stress- or shock-induced diffuse hair shedding)
• Alopecia areata (AA, autoimmune patchy hair loss)
• Lichen planopilaris (LPP, scarring inflammatory hair loss)

Mechanism of action

The precise mechanism through which minoxidil promotes hair growth is not fully understood, but several pathways have been identified.

• It upregulates VEGF to increase blood flow and deliver more oxygen and growth factors to the follicle.
• It activates potassium channels in the hair follicle, prolonging the anagen (growth) phase and shortening the telogen (resting) phase.
• It also stimulates dermal papilla cells via the Wnt/β-catenin pathway and may have immunoregulatory effects that could explain some efficacy in autoimmune alopecias like AA and LPP.

Topical vs. Oral

Both forms produce comparable results. The choice comes down to what you're willing to trade.

Going topical means keeping minoxidil where it belongs, e..g on the scalp, with minimal systemic absorption and no cardiovascular considerations. But you give up is convenience. The solution requires twice-daily application, can leave hair greasy. But you still have to apply it consistently to the right areas every day. People with thicker or denser hair also struggle to reach the full scalp surface, which matters for coverage.

Going oral removes all of that. One pill, full systemic coverage of the scalp and body regardless of hair density. Minoxidil is now circulating systemically, which means the same vasodilatory mechanism that grows hair can also cause hair elsewhere on the body, mild fluid retention, or a slight drop in blood pressure. These effects are well-documented and manageable at low doses.

If you do go topical, pair it with a derma stamp. Studies show the combination significantly outperforms topical minoxidil alone — microneedling creates temporary micro-channels in the scalp that bypass the stratum corneum, dramatically increasing how much minoxidil actually reaches the follicle. See the Topical Minoxidil protocol below.